Jim has been a member of the DAC team since 2018, in the role of Program Manager within the Health Technology Assessment and Network Analytics group. Diabetes research is a major focus and he brings a wide range of skills in health technology assessment, health services research, quantitative research, clinical trials and observational study design. Current work includes the use of provincial administrative data to guide diabetic retinopathy screening, a developmental evaluation to guide the development of a foot and wound care pathway for individuals living with diabetes and the network evaluation for Diabetes Action Canada.
Jim Bowan is a clinical research manager within the Toronto Health Economics and Technology Assessment (THETA) Collaborative and Program Manager for the Health Technology Assessment and Network Analytics program within Diabetes Action Canada. His research interests include the development of methods related to the conduct of clinical trials, and other studies, designed to help inform health policy decisions related to technologies and interventions used within the health system. He is a pharmacist and holds a Bachelor of Science in Pharmacy and Master of Science, specializing in pharmacology, from the Faculty of Pharmacy at the University of Toronto. He is also an Assistant Professor (part-time) in the Department of Health Research Methods, Evidence and Impact (HE&I), Faculty of Health Sciences at McMaster University where he provides instruction within the Health Research Methodology graduate program.